News Archive
BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the execution of the licensing agreement with Vestiq Pharmaceuticals to commercialize Oravig in the United States for the treatment of oropharyngeal candidiasis in adults.
The OA Self-Study App for iOS and Android devices is designed to help resident anesthesiologists, physicians, and those in the related health professions to improve their knowledge of basic and advanced concepts of the field.
Organogenesis Inc., a global leader in advanced wound care innovations and technologies, today announced that its PuraPly and PuraPly Antimicrobial (AM) wound management products are now eligible for Medicare coverage and reimbursement in 10 states, providing coverage for an additional 7.5 million Medicare beneficiaries, following the decision by National Government Services (NGS) to retire its local coverage determination (LCD) for cellular and tissue-based products (CTPs) effective September 1, 2016.
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
› Verified 5 days ago